Table 3 Characteristics of patients hospitalised between 2010 and 2021 due to ARF/RF and RHD from the inpatient register (n = 1463)
From: Rheumatic heart disease prevalence in Namibia: a retrospective review of surveillance registers
n (%) | RF (n= 739) | VHD (n= 724) | |
|---|---|---|---|
Sex | |||
Women | 883 (60) | 452 | 431 |
Men | 580 (40) | 287 | 293 |
Age during Hospitalisation | |||
0–9 years | 266 (18) | 149 | 117 |
10–19 years | 289 (20) | 152 | 137 |
20–29 years | 276 (19) | 116 | 160 |
30–39 years | 219 (15) | 97 | 122 |
40–49 years | 128 (8.8) | 60 | 68 |
≥ 50 years | 285 (19) | 165 | 120 |
Outcome of Hospital Stay | |||
Deceased | 44 (3.0) | 24 | 20 |
Discharged | 1,358 (93) | 677 | 681 |
Referred to other hospitals | 61 (4.2) | 38 | 23 |
Diagnosesa | |||
Acute Rheumatic Fever/Rheumatic Fever | 739 (51) | – | – |
Rheumatic Aortic Valve Disease | 31 (2.1) | – | – |
Rheumatic Mitral Valve Disease | 72 (4.9) | – | – |
Rheumatic Tricuspid Valve Disease | 10 (0.7) | – | – |
Multiple Valve Disease | 16 (1.1) | – | – |
Other Rheumatic Heart Disease | 481 (33) | – | – |
Non-rheumatic Valve Disease | 114 (7.8) | – | – |
Surgery | |||
None | 1 388 (95) | 724 | 664 |
Surgery | 75 (5.0) | 15 | 60 |
Days spent in Hospital | |||
0–9 days | 1,144 (78) | 610 | 534 |
10–19 days | 219 (15) | 87 | 132 |
20–29 days | 54 (3.7) | 23 | 31 |
30–above days | 46 (3.1) | 19 | 27 |